Drug-drug interaction prediction method and system based on non-negative tensor decomposition
A non-negative tensor decomposition and prediction method technology, applied in the field of computer-aided drug research, can solve problems such as unpredictability, costing a lot of money and time, and unexplainable reasons for drug interactions, achieving good stability and robustness , The process is fast, simple and convenient, and the effect of predicting the effect is good
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0036] Refer to attached figure 1 , this embodiment provides a drug-drug interaction prediction method based on non-negative tensor decomposition, comprising the following steps:
[0037] S01. Obtain the network data, drug characteristics and new drug characteristics of pharmacological type drug-drug interaction (DDI); specifically, the network data of pharmacological type DDI is a self-loop undirected network, denoted as G, G=(V , E, l); where V={v 1 , v 2 ,...,v m} is a collection of nodes in the network, each node represents a drug; E={e 1 , e 2 ,...,e c} is the set of edges between nodes, each edge represents a DDI, l={PK, PD} is the attribute of the set of edges. The adjacency matrix of the DDI network data is a single-type third-order tensor, denoted as Y (generalized adjacency matrix), which can be regarded as a stack of two adjacent matrices interacting with PK and PD types. If the drug d i with drugs d j If there is an interaction and the pharmacological type...
Embodiment 2
[0068] Refer to attached Figure 5 , this embodiment provides a system for realizing the non-negative tensor decomposition-based drug-drug interaction prediction method provided in the above embodiment 1, which includes: an acquisition module, a dimensionality reduction module, a training module, a prediction module and Evaluation module.
[0069] Among them, the obtaining module is used to obtain network data, drug characteristics and new drug characteristics of pharmacological types of drug-drug interactions.
[0070] The dimensionality reduction module is used to reduce the dimensionality of drug features and new drug features using the principal component analysis method based on kernel functions.
[0071] The training module is used to construct a training model through the non-negative tensor decomposition method according to the network data of pharmacological type drug-drug interaction and the drug feature after dimensionality reduction, so as to obtain the latent spa...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


